Novartis AG (NVSN) — Cash Flow Reinvestment Rate
Novartis AG (NVSN) has a Cash Flow Reinvestment Rate of 0.52x as of March 2026, reinvesting MX$1.92 Billion (capex MX$807.00 Million plus investments MX$1.11 Billion) from operating cash flow of MX$3.68 Billion. Explore NVSN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Novartis AG Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Novartis AG across 12 annual periods. Also explore total assets of Novartis AG for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Novartis AG (2014–2025)
Year-by-year capital reinvestment analysis for Novartis AG. For live market cap and broader valuation context, see NVSN market cap.
| Year | Reinvestment Rate | Total Reinvested (MXN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | MX$5.77 Billion | MX$19.14 Billion | MX$3.90 Billion | ▲ +37.4% |
| 2024 | 0.22x | MX$3.87 Billion | MX$17.62 Billion | MX$3.81 Billion | ▼ -60.0% |
| 2023 | 0.55x | MX$8.79 Billion | MX$16.02 Billion | MX$2.90 Billion | ▲ +33.5% |
| 2022 | 0.41x | MX$5.85 Billion | MX$14.24 Billion | MX$1.20 Billion | ▼ -24.4% |
| 2021 | 0.54x | MX$8.19 Billion | MX$15.07 Billion | MX$1.38 Billion | ▲ +237.8% |
| 2020 | 0.16x | MX$2.20 Billion | MX$13.65 Billion | MX$1.27 Billion | ▼ -51.9% |
| 2019 | 0.33x | MX$4.56 Billion | MX$13.62 Billion | MX$1.38 Billion | ▼ -60.6% |
| 2018 | 0.85x | MX$12.10 Billion | MX$14.27 Billion | MX$1.25 Billion | ▲ +690.9% |
| 2017 | 0.11x | MX$1.35 Billion | MX$12.62 Billion | MX$1.32 Billion | ▼ -80.5% |
| 2016 | 0.55x | MX$6.32 Billion | MX$11.47 Billion | MX$2.88 Billion | ▲ +134.2% |
| 2015 | 0.24x | MX$2.80 Billion | MX$11.90 Billion | MX$2.37 Billion | ▼ -46.4% |
| 2014 | 0.44x | MX$6.10 Billion | MX$13.90 Billion | MX$2.62 Billion | — |